- RecruitingPHASE2
NOV-ERA - A Clinical Trial to Assess the Efficacy and Safety of Ontunisertib Compared to Placebo in Patients With Fibrostenosing Crohn's Disease
This clinical trial is testing a new drug called ontunisertib for adults with Crohn's disease. Over time, scar tissue can narrow the bowel, causing pain, bloating, and blockages. Researchers want to see if ontunisertib can safely ease these blockages and improve symptoms compared with a dummy treatment (placebo).
For: Fibrostenotic Crohn's DiseaseUnited States · Serbia · United Kingdom - RecruitingPHASE1
Human Mass Balance Study of [14C] Ontunisertib in Healthy Volunteers
This study in healthy men aged 30-65 is looking at a new medicine called Ontunisertib, which might help people with a gut condition called Crohn's disease. Researchers want to understand how the body takes in, uses, and gets rid of this medicine, including how quickly and through what routes it leaves the body.
For: Fibrostenotic Crohn's DiseaseUnited Kingdom